An Open-Label, Phase 1 Safety and Phase 2 Randomized Study of JCAR017 in Subjects with Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma (017004)
Administered By
Awarded By
Contributors
- Brander, Danielle Marie Principal Investigator
Start/End
- July 24, 2019 - June 30, 2024